Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJudges Scientific Regulatory News (JDG)

Share Price Information for Judges Scientific (JDG)

Share Price is delayed by 15 minutes
Get Live Data
4,725.00    125.00 (2.72%)
Bid:
4,650.00
Ask:
4,800.00
Spread: 150.00 (3.226%)
Market Cap: £314.72m
JDG Live PriceLast checked at - London Stock Exchange

Intraday Judges Scientific Share Chart

Statement regarding COVID-19

24 Feb 2020 07:00

RNS Number : 8242D
Judges Scientific PLC
24 February 2020
 

24 February 2020

Judges Scientific plc

("Judges Scientific", "Judges", the "Company" or the "Group")

Statement regarding COVID-19

 

The Board of Judges continues to closely monitor developments in China and the potential effect of the COVID-19 epidemic on its business.

With the current scale of the outbreak, and provided it does not last more than three months and remains largely contained within China, it is not expected that there will be a significant impact to the Group's 2020 trading.

The Group operates with an average 3-month order book, so in the near term the current travel restrictions are expected to only have a temporary impact, deferring rather than reducing revenue. Unaudited revenues for China/Hong Kong represented £9.5 million in 2019.

In relation to Judges' supply chain, direct and indirect supply from China varies from business to business in the Group, with only one subsidiary having significant supply chain exposure. The Board is monitoring developments closely and at this stage of the outbreak, currently considers that supply chain disruptions will be manageable.

The situation remains under active review by the Board.

 

Judges Scientific

 

 

David Cicurel, CEO

Brad Ormsby, Group FD

Tel: +44 (0) 20 3829 6970

 

 

Shore Capital (Nominated Adviser & Broker)

 

Stephane Auton

Edward Mansfield

Sarah Mather

Tel: +44 (0) 20 7408 4090

 

Liberum (Joint Broker)

Bidhi Bhoma

Euan Brown

 

Media enquiries:

Alma PR (Financial Public Relations)

 

Tel : +44 (0) 20 3100 2222

 

Rebecca Sanders-Hewett

Sam Modlin

 

Tel: +44 (0) 20 3405 0205

judges@almapr.co.uk

 Notes to editors:

Judges Scientific plc (AIM: JDG), is a group involved in the buy and build of scientific instrument businesses. The Group currently consists of 17 businesses acquired since it was re-admitted to AIM in 2005.

The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, the scientific communities, manufacturers and regulatory authorities. The UK is a recognised centre of excellence for scientific instruments. The Group has received five Queen's Awards for innovation and export.

The Group's companies predominantly operate in global niche markets, with long term growth fundamentals and resilient margins.

Judges Scientific maintains a policy of selectively acquiring businesses that generate sustainable profits and cash. Shareholder returns are created through the repayment of debt, organic growth and dividends.

For further information, please visit www.judges.uk.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
STREAEADAFAEEAA
Date   Source Headline
23rd Apr 20125:24 pmRNSExercise of Options
18th Apr 20125:46 pmRNSExercise of Options
30th Mar 20123:49 pmRNSDirector/PDMR Shareholding and Exercise of Options
29th Mar 20127:00 amRNSFinal Results
12th Mar 20126:17 pmRNSHolding(s) in Company
7th Mar 20127:00 amRNSACQUISITION OF GLOBAL DIGITAL SYSTEMS LIMITED
22nd Feb 201210:00 amRNSAcquisition of KE Developments Limited
19th Jan 20127:00 amRNSTrading Statement
16th Nov 20117:00 amRNSTrading Statement
6th Oct 201111:59 amRNSDirector/PDMR Shareholding and Exercise of Options
28th Sep 20117:00 amRNSHalf Yearly Report
14th Sep 20117:00 amRNSNotice of Results
22nd Jul 20115:04 pmRNSDirector/PDMR Shareholding
18th Jul 20117:00 amRNSTrading Statement
27th May 20117:00 amRNSIssue of Equity
26th May 20114:28 pmRNSDirector/PDMR Shareholding
10th May 20117:00 amRNSDirector/PDMR Shareholding
28th Apr 20119:25 amRNSHolding(s) in Company
15th Apr 20115:03 pmRNSDirector/PDMR Shareholding
7th Apr 20112:48 pmRNSHolding(s) in Company
5th Apr 20116:05 pmRNSDirector/PDMR Shareholding
5th Apr 20115:44 pmRNSDirector/PDMR Shareholding
4th Apr 20116:28 pmRNSDirector/PDMR Shareholding
1st Apr 201110:51 amRNSHolding(s) in Company
30th Mar 20117:00 amRNSFinal Results
21st Mar 20117:00 amRNSAcquisition
4th Mar 20117:00 amRNSNotice of Results
20th Jan 20117:00 amRNSTrading Statement
13th Jan 201111:10 amRNSDirector/PDMR Shareholding
22nd Nov 20105:20 pmRNSExercise of options
17th Nov 20107:00 amRNSTrading Statement
11th Oct 20106:17 pmRNSHolding(s) in Company
28th Sep 20107:00 amRNSExercise of Options
22nd Sep 20107:00 amRNSHalf Yearly Report
9th Sep 20102:00 pmRNSNotice of Results
21st Jul 201012:08 pmRNSHolding(s) in Company
20th Jul 201012:04 pmRNSHolding(s) in Company
20th Jul 20109:13 amRNSDirector/PDMR Shareholding
16th Jul 20107:00 amRNSTrading Statement
25th May 201012:17 pmRNSResult of AGM
21st May 20109:35 amRNSIssue of Equity
26th Mar 20107:00 amRNSFinal Results
19th Mar 20107:00 amRNSAcquisition
4th Mar 20105:25 pmRNSNotice of Results
22nd Jan 201011:15 amRNSShare buyback programme
22nd Jan 20107:00 amRNSTrading Statement
14th Jan 201010:20 amRNSHolding(s) in Company
11th Dec 20097:00 amRNSTrading Statement
20th Oct 200910:55 amRNSExercise of options
2nd Oct 20097:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.